Home › Funds › Artia Global Partners LP › KNSA

Artia Global Partners LP position in KNSA

KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A · Health Care

Artia Global Partners LP reported holding 29,200 shares of KNSA (KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A) in its Q2 2026 13F filing — a position valued at US$1.9M, representing 0.34% of its reported portfolio and ranking #41 among its reported holdings. Artia Global Partners LP has disclosed KNSA holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)29.20K sh
Reported value held$1.87M
Portfolio Weight0.34%
First reportedQ2 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Artia Global Partners LP's KNSA position evolved

Artia Global Partners LP first disclosed a stake in KNSA in Q2 2025 at 29,200 shares (US$808K). The position peaked in Q2 2026 at 29,200 shares, worth US$1.9M. Across 5 filings, Artia Global Partners LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 29,200 shares valued at US$1.9M.

Quarter by quarter

QuarterSharesValueChange
Q2 2025 29.20K $807.96K New
Q3 2025 29.20K $1.13M Hold
Q4 2025 29.20K $1.20M Hold
Q1 2026 29.20K $1.41M Hold
Q2 2026 29.20K $1.87M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KNSA and 13F data

KNSA (KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A) is a Health Care company. 49 other funds we track also report a position in KNSA — the largest reported positions include Rubric Capital Management LP (US$255.8M), BAKER BROS. ADVISORS LP (US$181.3M), TANG CAPITAL MANAGEMENT LLC (US$144.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KNSA

All KNSA fund holders →

FAQ

How long has Artia Global Partners LP held KNSA?

Artia Global Partners LP has disclosed KNSA holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is Artia Global Partners LP's current position in KNSA?

As of Q2 2026, Artia Global Partners LP holds 29.20K shares of KNSA (KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A), valued at $1.87M, representing 0.34% of its reported portfolio and ranking #41.

Has Artia Global Partners LP been buying or selling KNSA?

In the latest 13F filing (Q2 2026), Artia Global Partners LP held unchanged its position in KNSA. The position peaked in Q2 2026 at 29.20K shares.

Which other funds hold KNSA?

Other major institutional holders of KNSA include Rubric Capital Management LP, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.